Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edoardo Missiaglia

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 28, 2012
Inconvenience of convenience cohorts--letterDaniel Williamson, Edoardo Missiaglia, Julia Chisholm, et al.
Sarcoma|March 26, 2011
Targeting the insulin-like growth factor pathway in rhabdomyosarcomas: rationale and future perspectivesAna Sofia Martins, David Olmos, Edoardo Missiaglia, et al.
Journal of Clinical Pathology|April 16, 2011
Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomasKhin Thway, Joanna Selfe, Edoardo Missiaglia, et al.
Cell Reports|October 2, 2012
Mpn1, mutated in poikiloderma with neutropenia protein 1, is a conserved 3'-to-5' RNA exonuclease processing U6 small nuclear RNAVadim Shchepachev, Harry Wischnewski, Edoardo Missiaglia, et al.
Oncogene|January 8, 2005
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathwayEdoardo Missiaglia, Massimo Donadelli, Marta Palmieri, et al.
Virchows Archiv : an International Journal of Pathology|April 12, 2018
Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphomaAudrey Letourneau, Marie Maerevoet, Dina Milowich, et al.
Neoplasia (New York, N.Y.)|April 3, 2007
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumorsIrene Dalai, Edoardo Missiaglia, Stefano Barbi, et al.
Endocrine Pathology|January 26, 2020
Gallbladder Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN) Arising in Intracholecystic Papillary Neoplasm: Clinicopathologic and Molecular Analysis of a Case and Review of the LiteratureAmedeo Sciarra, Edoardo Missiaglia, Mounir Trimech, et al.
International Journal of Cancer|March 29, 2002
Sex chromosome anomalies in pancreatic endocrine tumorsEdoardo Missiaglia, Patrick S Moore, Jill Williamson, et al.
Electrophoresis|December 18, 2003
Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidineDaniela Cecconi, Hubert Astner, Massimo Donadelli, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 28, 2012
Inconvenience of convenience cohorts--letterDaniel Williamson, Edoardo Missiaglia, Julia Chisholm, et al.
Sarcoma|March 26, 2011
Targeting the insulin-like growth factor pathway in rhabdomyosarcomas: rationale and future perspectivesAna Sofia Martins, David Olmos, Edoardo Missiaglia, et al.
Journal of Clinical Pathology|April 16, 2011
Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomasKhin Thway, Joanna Selfe, Edoardo Missiaglia, et al.
Cell Reports|October 2, 2012
Mpn1, mutated in poikiloderma with neutropenia protein 1, is a conserved 3'-to-5' RNA exonuclease processing U6 small nuclear RNAVadim Shchepachev, Harry Wischnewski, Edoardo Missiaglia, et al.
Oncogene|January 8, 2005
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathwayEdoardo Missiaglia, Massimo Donadelli, Marta Palmieri, et al.
Virchows Archiv : an International Journal of Pathology|April 12, 2018
Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphomaAudrey Letourneau, Marie Maerevoet, Dina Milowich, et al.
Neoplasia (New York, N.Y.)|April 3, 2007
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumorsIrene Dalai, Edoardo Missiaglia, Stefano Barbi, et al.
Endocrine Pathology|January 26, 2020
Gallbladder Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN) Arising in Intracholecystic Papillary Neoplasm: Clinicopathologic and Molecular Analysis of a Case and Review of the LiteratureAmedeo Sciarra, Edoardo Missiaglia, Mounir Trimech, et al.
International Journal of Cancer|March 29, 2002
Sex chromosome anomalies in pancreatic endocrine tumorsEdoardo Missiaglia, Patrick S Moore, Jill Williamson, et al.
Electrophoresis|December 18, 2003
Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidineDaniela Cecconi, Hubert Astner, Massimo Donadelli, et al.
Pageof 7